Please provide your email address to receive an email when new articles are posted on . Christopher H. Lieu, MD, has been elected vice chair. “The exemplary leadership from our board of directors is ...

PLYMOUTH MEETING, PA [October 9, 2025] — New research published online in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much lower ...

Outcomes of patients with metastatic solid cancers treated on early phase clinical trials in western Australia. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...

PLYMOUTH MEETING, PA [April 29, 2026] — The National Comprehensive Cancer Network ® (NCCN ®)—an alliance of leading cancer centers—announces several recent external awards and publications honoring ...

The guidelines state that a test must be FDA-approved, personalized, tumor-informed, multiplex, and use PCR-NGS for ctDNA.

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Today, the National Comprehensive Cancer Network ® (NCCN ®)-a nonprofit responsible for globally utilized guidelines for cancer care-is sharing new NCCN Guidelines Navigator™ resources for breast ...

In a recent update, the National Comprehensive Cancer Network (NCCN) recommended capivasertib combined with fulvestrant for hormone receptor–positive and HER2-negative locally advanced or metastatic ...

The National Comprehensive Cancer Network (NCCN) and OpenEvidence, an AI-enabled medical information platform for doctors, announced a licensing agreement to make NCCN’s evidence-based oncology ...

This study evaluates inclusion of National Comprehensive Cancer Network (NCCN) guideline recommended biomarkers for metastatic non–small cell lung cancer (NSCLC) in commercially available targeted ...

Source: Getty Images The NCCN’s updated guidelines for the treatment of breast cancer include updates on sentinel lymph node biopsy, ovarian function suppression, and the use of prognostic tools. The ...

Please provide your email address to receive an email when new articles are posted on . NCCN recommends osimertinib plus chemotherapy or lazertinib plus amivantamab-vmjw as first-line options for EGFR ...